Speech of Kids After Neonatal Encephalopathy
Recruiting
Observational Study
HIE - Hypoxic - Ischemic Encephalopathy
Language Delay
Autism
ADHD - Attention Deficit Disorder With Hyperactivity
Specific Language Impairment
Intellectual Developmental Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 – 7
- Sex
- Any
- Study type
- Observational
- Participants needed
- 93 (estimated)
- Sponsor
- Semmelweis University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this ambispective cohort study is to reveal the early indicators of delayed language development in children born with hypoxic-ischemic encephalopathy (HIE).
We will examine the prognostic accuracy of different biomarkers, with a special focus on the ADC values of the corpus callosum.
The main questions it aims to answer are:
1. To what extent does hypoxic-ischemic encephalopathy (H…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Children born between 2017 and 2023 with moderate to severe HIE, treated with therapeutic hypothermia at Semmelweis University Children's Hospital.
Inclusion criteria
1. Born at ≥ 35th week of gestation
2. Attended follow-up examinations at two years of age
3. Has parental informed consent
Exclus…
Contacts
No contact information available.